News
The European Union has approved Novartis's <NOVN.VX> Exelon skin patch to treat Alzheimer's disease, the Swiss drugmaker said on Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback